In this session, Dr. Gregory Hall will provide a foundation of information including current statistics and demographics of African Americans’ health. He will review trust and bias issues as well as their origins in the history of healthcare of African Americans. Finally, he will provide some examples of important differences in the clinical care of African Americans as he sets the stage for more detailed discussion in future sessions of this monthly webcast. Dr. Hall is a Primary Care Physician and an expert in Black American Health and Healthcare. He is the former chair of the Ohio Commission on Minority Health, Director of the National Center for African American Health, Research, Education and Policy at Cleveland State University, and Author of “Patient-Centered Clinical Care for African Americans: A Concise, Evidence-Based Guide to Important Differences and Better Outcomes”. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 07/14/2021 and they are subject to change as new information is published.

National lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, explore novel targets and treatment pathways, and apply the 2018 AHA/ACC Cardiology Cholesterol Guidelines. Learners will have gain practical clinical perspectives during expert case study discussions, including how new treatment options may fit into the current therapeutic landscape.

In the seventeenth episode of Pri-Med’s weekly web series on COVID-19, faculty will explore how the COVID-19 pandemic has influenced non-communicable diseases and impacted healthcare beyond SARS-CoV-2 infection. Faulty will also discuss the role of masks to reduce the risk of respiratory infections and compare the efficiency of different masks. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 09/01/2020 and they are subject to change as new information is published.

Join Dr. Frank Domino as he discusses an evidence-based approach to diagnosing and managing a condition frequently seen in primary care practice: shoulder pain. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 26th, 2020 and they are subject to change as new information is published.

This session will provide primary care clinicians with a foundational understanding of the pathophysiology of obesity. We will review the 4-pillar concept of obesity treatment and provide practical skills for applying nutritional interventions, physical activity recommendations, behavioral therapy approaches, and medication treatments for patients with obesity.

1. Review obesity and diabetes trends and health disparities in the US 2. Review body image and perception differences by race/ethnicity 3. Describe best practices in the treatment of diabetes in African Americans 4. Examine the difference in HbA1c interpretations in African Americans and related clinical considerations

Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.

What’s new in prostate cancer screening? Tune in to this webcast for the latest guidelines, screening methods, and data on the role of multi-parametric MRI of the prostate in screening and diagnosis of prostate cancer.

Cannabis use continues to rise in the United States, driven by expansion of laws legalizing recreational and medical use. With this increased use comes an increase in side effects, such as lung injuries from vaping and a rise in cannabis use disorder. We will discuss what practitioners should know about vaping and cannabis use, and what they should tell their patients. This session will also inform the attendees the most recent clinical and radiographic findings in patients diagnosed with e-cigarette and vaping associated acute lung injury.

As we see more patients with cognitive impairment, understanding the real-world care for this population is vital. This lecture will review the most efficient means of assessing cognitive impairment, examine common issues in caring for the older adult with cognitive impairment, and discuss pharmacologic/non-pharmacologic means of treating patients. Dr. Lindquist will also address updates on what medications are useless/useful and what testing should be avoided. Polypharmacy is common among older adults and associated with adverse outcomes. This case-based session will review how to avoid inappropriate prescribing, recognize adverse drug events, and identify opportunities to deprescribe. Dr. Bradley will review recent literature updates that inform our prescribing practices including the 2019 AGS Beers criteria. Tips to enhance safe medication use will be shared. The updates will be followed by an “Ask the Expert” session with Drs. Lindquist and Bradley where they will review common questions and take questions from attendees.

This talk will cover the potential and the challenges in genetic discovery that need to be met in order to support the utility of genomics in clinical care. Genome methods including whole genome sequencing will be covered. The successes in pediatric genetics will be contrasted with the greater challenges in adult medicine.

Asthma & chronic obstructive pulmonary disease (COPD) can have overlapping symptoms, but they are characterized by different pathogenic mechanisms and different responses to anti-inflammatory therapies. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms. But how should we approach these patients? What’s new in asthma and COPD? This case-based presentation will help you review what you need to know about asthma and COPD in 2020.